Igor Watson

Doctor of Osteopathic Medicine,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Case Consulting Research Consulting Sales and Marketing

Areas Of Interest

Species Extinctions Ventriculomegalies, Fetal Cerebral beta-Caveolin Neoplasms, Breast, Male Stem Cell, Erythropoietic Endocrine Neoplasia, Multiple Low-Carbohydrate Diet Desulfitobacterium Esophagostomy, Cervical Pre-Existing Condition Palavit Sling, Midurethral Infections, Rickettsiaceae Activating Transcription Factors Tenakrin Subunit, Small Ribosomal Transcription Factor GATA3 Sentinel Health Event Head Kidney Lantanas Costs, Disease Illnesse, Occupational Encephalitozoon cuniculus Computed Tomographic Scintigraphy Drunkennesses, Sleep Hereditary Mucosal Leukokeratosis Splanchnoptosis

Professional Narrative

Dr. Igor Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2000
Executive Director, Harvard Med 1992

Education

Doctor of medicine, Yale School of Medicine 1988
Director Medicine, Yale School of Medicine 2006

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :